Medical/Pharmaceuticals
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA
BOSTON and BEIJING, July 7, 2021 /PRNewswire/ -- Eucure Biopharma, a wholly
owned subsidiary of Biocytogen
2021-07-07 16:41
2235
Elekta optimizes treatment times for cancer patients via proactive service innovation
STOCKHOLM, July 7, 2021 /PRNewswire/ -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at cancer clinics, thereby ensuring that patients receive timely radiotherapy. Among these solutions ...
2021-07-07 14:38
32301
Innophys' MUSCLE SUIT Selling Steadily after Topping 20,000 Units
TOKYO, July 7, 2021 /PRNewswire/ -- Developed and sold by Innophys Co., Ltd., MUSCLE SUIT has been selling steadily even after exceeding 20,000 units in cumulative total (*1) all over the world recently, making it a fast-selling (*2) exoskeleton assist suit in the world. Notes: (*1) Total numbe...
2021-07-07 14:00
2720
CStone announces China NMPA acceptance of IND application for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody-based molecule, marking further expansion of its Pipeline 2.0 strategy
SUZHOU, China, July 7, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigational new ...
2021-07-07 08:05
2795
New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta®
* STELFONTA® (tigilanol tiglate) is now approved by the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the treatment of canine non-metastatic mast cell tumours (MCT). * APVMA approval follows marketing authorisation (registration) and launch of STELFONTA® in the major co...
2021-07-07 06:34
1732
Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax
PROVIDENCE, R.I., July 7, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr.Amy Rosenberg is leaving the FDA's Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and Protein Therapeutics. Dr. Rosenber...
2021-07-07 01:43
2211
Transcenta Announces NMPA Acceptance of IND Application of its Anti-Sclerostin Monoclonal Antibody TST002
SUZHOU, China, July 6, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announces that NMPA has accepted IND applica...
2021-07-06 21:36
1663
RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally
TORONTO, July 6, 2021 /PRNewswire/ -- RamSoft, a leading healthcare IT software and services company, today announced it has taken a majority stake in Meddiff Technologies, an innovative medical imaging solutions company. This acquisition will accelerate RamSoft's product development by combining...
2021-07-06 21:00
1585
Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility
XIAN, China, July 6, 2021 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solutions provider in the natural, health and personal care industries, today announced that they have received the certificate of a land use right for the future si...
2021-07-06 21:00
3972
Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market
* Seegene announces partnership with Bio-Rad for the development and commercialization of infectious disease molecular diagnostic products * Diagnostic tests designed for the pandemic and the post-pandemic era with high multiplex technology * A significant step forward for Seegene in expandi...
2021-07-06 18:00
1854
PolyU develops highly sensitive, microscopic optical fibre sensors with pioneering biomedical monitoring capability
HONG KONG, July 6, 2021 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) has made a breakthrough development in optical fibre sensors, making the advanced railway safety monitoring technologies available for medical surveillance inside the human body. The research team led by Profess...
2021-07-06 17:06
1432
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate
* SPECTRA enrolled over 29,000 adult and elderly participants across four continents achieving high ethnic diversity and robust dataset of circulating strains * Release of vaccine efficacy data anticipated in Q3 2021 and will include sequencing data of SARS-CoV-2 variants of concern and varia...
2021-07-06 14:00
2514
Bora Group announce the rebranding of Yuta Health to Bora Health
TAIPEI, July 6, 2021 /PRNewswire/ -- Leading Taiwan-based contract development and manufacturing organization (CDMO) Bora Group today announced a name change for its subsidiary, currently Yuta Health, to Bora Health Inc. as part of an overall plan to integrate its distribution operations and b...
2021-07-06 13:31
2469
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
SAN FRANCISCO and SUZHOU, China, July 6, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...
2021-07-06 08:00
4422
Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis (MF)
SHANGHAI and HONG KONG, July 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-07-06 08:00
3410
South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology
DAEJEON, South Korea and CASTRES, France, July 6, 2021 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have entered into a license agreement granting worldwide exclusive rights toPierre Fabre to develop and commercialize a family of hum...
2021-07-06 07:00
2792
SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting
TIANJIN, China, July 5, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, today announced that they have teamed up with the National University of Ireland Galway (NUI Galway) to conduct a clinical trial for a new assessment method for stenting. The trial will employ the...
2021-07-05 19:42
2534
Octapharma's ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress
LACHEN, Switzerland, July 5, 2021 /PRNewswire/ -- Octapharma announced today that new clinical and scientific findings encompassing their Haematology portfolio, including Nuwiq®, wilate®, octanate® and octanine®F, will be presented at the upcoming International Society on Thrombosis and Haemostas...
2021-07-05 19:30
2374
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories
SHANGHAI, July 5, 2021 /PRNewswire/ -- Everest Medicines
2021-07-05 18:16
3445
Tianjin Haihe Media Group presents an extraordinary story of a TCM doctor and his battle against COVID-19 in China
TIANJIN, China, July 3, 2021 /PRNewswire/ -- Zhang Boli, director of the Tianjin University of Traditional Chinese Medicine inChina, was awarded with the national honorary title "the People's Hero" by the Chinese central government for his outstanding contribution to the country's fight against t...
2021-07-05 09:14
4219
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 284 media titles]
2024-11-29 20:33
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
7064
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5172